Back to Agenda
Welcome, Opening Remarks and Session 1: Keynote Address
Session Chair(s)
Robin M. Weinick, PhD
SVP/Managing Director Americas and Global Program Officer
DIA, United States
Welcome, Opening Remarks and Session 1: Keynote Address
Speaker(s)
Speaker
William Chong, MD
FDA, United States
Associate Director for Clinical Affairs, Office of Generic Drugs, CDER
Welcome, Opening Remarks and Session 1: Keynote Address
Thinh X. Nguyen
FDA, United States
Director, Office of Combination Products, OCPP
Have an account?